Led by Nimit Tien-Udom,director of the Aids Access Foundation,the group stepped in after hearing that Gilead,the manufacturer of sofosbuvir,a drug for treating hepatitis C.
Led by Nimit Tien-Udom,director of the Aids Access Foundation,the group stepped in after hearing that Gilead,the manufacturer of sofosbuvir,a drug for treating hepatitis C.